| Literature DB >> 31728247 |
Abstract
Background This work explores the opinions and expectations of ultramarathon runners about medical services and their perceived quality during ultramarathons. Methods Focused questions related to medical services at ultramarathons were included in the 2018 survey of Ultrarunners Longitudinal TRAcking (ULTRA) Study enrollees. Results Among the 1,156 respondents, 83.2% agreed that ultramarathons should provide at least a minimum level of medical support with basic first aid and emergency transport services rated as the most important medical services, and individuals with basic first aid training rated as the most important medical providers at ultramarathons. Participant safety was felt to largely be the responsibility of each runner as well as the race and/or medical director. Among 832 respondents having completed an ultramarathon in 2016-2018, their impression of medical services at 4,853 ultramarathons was generally favorable. Of the four percent of times in which medical support was needed, it met expectations 74% of the time. Of the total of 240 different medical issues for which medical support was needed, blister management was the most common, accounting for 26.7% of issues. Conclusions Even though medical services receive minimal utilization during ultramarathons, ultramarathon runners largely believe that these events should provide at least a minimum level of medical support. Ultramarathon runners place a high onus for safety during ultramarathons on themselves, but they also place a high level of responsibility on race and medical directors, so it is prudent for the race and medical directors to consider this information and avoid a mismatch between runner expectations and the medical services actually provided.Entities:
Keywords: blister; emergency medical services; global positioning systems; medical care team; running; wilderness medicine
Year: 2019 PMID: 31728247 PMCID: PMC6827872 DOI: 10.7759/cureus.5800
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Selected characteristics of the respondents answering the question “Should ultramarathons provide at least some minimum level of medical support?”
Full group n=1,156; respondents who replied "yes" n=962 (83.2%); respondents who replied "no" n=194 (16.8%).
Data are presented as median value (with interquartile range) or as a percentage. The p-values are for comparison of the two subgroups.
a Twelve years equates to completion of high school and scale was capped at 18 years (six years or more following completion of high school).
b The question was phrased “Would you like to see more pre-race medical and science presentations at ultramarathons you participate in? Yes or No.”
| Characteristic | Full group | Yes-group | No-group | p-value |
| Age (years) | 49 (41-57) | 49 (40-57) | 49 (42-57) | 0.15 |
| Sex (% men) | 66.5 | 64.7 | 75.8 | 0.0026 |
| Home country (% from US) | 86.8 | 86.7 | 87.1 | 1.00 |
| Schooling completed (years)a | 18 (16-18) | 18 (16-18) | 18 (16-18) | 0.59 |
| Time since first ultramarathon (years) | 10 (8-15) | 10 (8-15) | 11 (8-16) | 0.014 |
| Completed an ultramarathon in 2014-2018 (%) | 85.1 | 84.7 | 87.1 | 0.44 |
| Ultramarathons started in prior two years (n) | 3 (0-6) | 2 (0-6) | 4 (0-8) | 0.0015 |
| Wanting more pre-race medical/science presentations (%)b | 65.8 | 67.6 | 57.1 | 0.0058 |
Explanations provided by those who responded "no" to the question “Should ultramarathons provide at least some minimum level of medical support?”
Explanations are provided by 16.8% of respondents. Note that respondents could select multiple reasons.
| Explanation | Affirmed (%) |
| Participants should be able to take care of themselves | 68.0 |
| Will add to the cost of participating | 23.2 |
| Not necessary because medical issues are not usually serious | 11.3 |
| Not necessary because medical issues are rare | 7.2 |
| Other | 39.7 |
Importance ratings by ultramarathon runners for three aspects of safety and medical services during an ultramarathon
Ratings were on a scale (with numeric rating) of very important (1), important (2), moderately important (3), slightly important (4), and not important (5). The initial set of responses were by all respondents, whereas the ratings on importance of specific medical services and medical providers were only by the 83.2% of respondents indicating they believed that ultramarathons should provide at least some minimum level of medical support. All pairwise comparisons within a topic differed (p<0.001) except between pairs with the same superscript letters.
NSAIDs - nonsteroidal anti-inflammatory drugs
| Safety or medical aspect | Importance rating (mean ± SD) |
| Responsibility for assuring participant safety | |
| Each participant | 1.4 ± 0.7 |
| Race and/or medical director | 1.5 ± 0.7 |
| Organizing body for the sport | 2.7 ± 1.3a |
| Local authorities | 2.7 ± 1.2a |
| Importance of specified medical services | |
| Basic first aid | 1.2 ± 0.5 |
| Emergency transport | 1.9 ± 1.0 |
| Wound management | 2.4 ± 1.0a |
| Automated external defibrillator (AED) | 2.4 ± 1.3a |
| Blister care | 2.7 ± 1.3 |
| Intravenous (IV) hydration | 3.1 ± 1.3 |
| On-site blood testing for hyponatremia | 3.5 ± 1.3b |
| Medications (e.g., NSAIDs, acetaminophen, anti-nausea) | 3.5 ± 1.2b |
| On-site blood or urine testing for potential kidney injury | 3.6 ± 1.2b |
| Importance of specified medical providers | |
| Individual with basic first aid training | 1.6 ± 0.9 |
| Emergency medical technician (EMT) | 2.2 ± 1.2a |
| Paramedic | 2.3 ± 1.2a |
| Nurse | 2.9 ± 1.2b |
| Person skilled at blister management | 3.1 ± 1.3b |
| Physician | 3.1 ± 1.3b |
| Massage therapist | 4.0 ± 1.1c |
| Physical therapist | 4.2 ± 1.0c |
| Podiatrist | 4.4 ± 0.9d |
| Chiropractor | 4.5 ± 0.8d |
Responses about which medications should be made available at ultramarathons
Percentages are among the 49% that did not indicate that "no medication should be made available". Note that respondents could select multiple medication choices.
NSAIDs - nonsteroidal anti-inflammatory drugs
| Medication | Affirmed (%) |
| Acetaminophen/paracetamol | 66.3 |
| NSAIDs | 63.8 |
| Anti-nausea medication | 58.3 |
| Other | 8.1 |
Responses to the question “Which environmental conditions would be appropriate to consider cancelling or stopping a race?”
Percentages are among the subset of 78.2% answering "yes" to the question “Should race and/or medical directors cancel or stop an ultramarathon if environmental conditions might significantly increase the health risks of participants?” Multiple responses were allowed.
| Response options | Affirmed (%) |
| Nearby wildfire | 88.1 |
| Severe smoke | 84.0 |
| Flooding | 82.2 |
| Blizzard conditions | 75.9 |
| Lightning | 59.5 |
| Public health crisis taxing the local medical system | 49.9 |
| Severe smog | 48.2 |
| Extreme heat | 43.8 |
| Extreme cold | 38.5 |
| Other | 6.8 |
Observations on medical support from ultramarathon runners who provided information on ultramarathons in which they participated during 2016-2018
Observations are collected from 832 ultramarathon runners who participated in 4,853 ultramarathons. Most (86.5%) of the ultramarathons were in the US and relate to race distances of (or approximating) 50 km (44.2%), 80 km (19.8%), 100 km (10.5%), 161 km (17.8%) and other distances (7.7%). Runs in which medical support was not needed (96%) were directed to question 2, and the 4% of runs in which medical support was needed (accounting for a total of 240 different medical issues) were directed to questions 3 and 4.
| Question | Answer (%) |
| 1. Was formal medical support provided? | |
| Yes | 49.4 |
| No | 19.9 |
| Unsure | 30.7 |
| 2. Did the available medical support seem adequate? | |
| Yes | 60.9 |
| No | 3.2 |
| Unsure | 36.0 |
| 3. Did the medical support meet your expectations? | |
| Yes | 74.0 |
| No | 13.0 |
| Partially | 13.0 |
| 4. For what did you need medical support? | |
| Blister management | 26.7 |
| Musculoskeletal injury (sprain, strain, cramping, bruise) | 16.3 |
| Wound management | 12.9 |
| Nausea | 12.5 |
| Dehydration | 10.8 |
| Hypothermia | 3.8 |
| Hyponatremia | 2.5 |
| Asthma | 1.7 |
| Other | 12.9 |